Society of Neuro-Oncology

Society of Neuro-Oncology
Name	Society of Neuro-Oncology
Abbreviation	SNO
Formation	1995
Headquarters	Chicago, Illinois
Region served	International
Membership	Clinicians, researchers, allied professionals
Leader title	President

Society of Neuro-Oncology

The Society of Neuro-Oncology is a professional association for clinicians and researchers focused on neuro-oncology, bringing together specialists from institutions such as Massachusetts General Hospital, Mayo Clinic, Johns Hopkins Hospital, Memorial Sloan Kettering Cancer Center and UCSF Medical Center to advance care for patients with brain and spinal tumors. It serves as a hub connecting stakeholders from National Institutes of Health, European Organisation for Research and Treatment of Cancer, National Cancer Institute, World Health Organization and academic centers like Harvard Medical School, Stanford University School of Medicine, University of Oxford through meetings, publications and guideline development. The organization works alongside professional societies including American Association for Cancer Research, American Society of Clinical Oncology, European Society for Medical Oncology, American Academy of Neurology and advocacy groups such as National Brain Tumor Society and Brain Tumour Charity.

History

Founded in 1995, the society emerged from collaborations among investigators at Brigham and Women's Hospital, Cleveland Clinic, University of California, San Diego School of Medicine and Vanderbilt University Medical Center who sought coordinated research comparable to multicenter efforts like those led by Cooperative Groups and consortia such as Radiation Therapy Oncology Group and Children's Oncology Group. Early leadership included faculty with appointments at Yale School of Medicine, Columbia University Irving Medical Center, University of Pennsylvania Perelman School of Medicine and University of Toronto, linking North American and European research agendas exemplified by initiatives from European Brain Council and Cancer Research UK. Over time the society expanded international reach with members from Karolinska Institutet, Istituto Europeo di Oncologia, Universidad Autónoma de Madrid and University of Tokyo, aligning with global efforts like the Global Neuro-Oncology Consortium and multinational trials registered with ClinicalTrials.gov.

Mission and Activities

The society's mission emphasizes clinical care, translational science and policy advocacy through partnerships with National Comprehensive Cancer Network, American Society of Radiation Oncology, Society for Neuro-Oncology Latin America, Asian Society for Neuro-Oncology and patient organizations such as American Brain Tumor Association. Activities include organizing scientific programs informed by investigators from Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, Sloan Kettering Institute, Institut Curie and technology collaboration with Siemens Healthineers, GE Healthcare and Philips Healthcare. Initiatives address biomarker development from groups like The Cancer Genome Atlas and therapeutics pipelines involving companies such as Roche, Novartis, Pfizer and Merck & Co..

Membership and Governance

Membership comprises neurosurgeons from departments at Barrow Neurological Institute and University of Michigan Health System, neuro-oncologists from Mayo Clinic Cancer Center and UCLA Health, neuropathologists from Johns Hopkins Hospital Department of Pathology and radiation oncologists affiliated with MD Anderson Cancer Center. Governance features a board including representatives with ties to Society for Neuro-Oncology Australasia, Canadian Cancer Society, European Association of Neuro-Oncology and academic affiliates such as King's College London and McGill University. Committees mirror structures seen in Institute of Medicine reports and collaborate with funders like Wellcome Trust, National Health and Medical Research Council and philanthropic entities including Gates Foundation.

Annual Meetings and Conferences

The society convenes annual meetings that attract presenters from American Association for the Advancement of Science, European Brain Tumor Symposium, International Conference on Brain Tumour Research and workshop partners like Society for Neuroscience. Sessions showcase research from centers such as University of Pennsylvania, Northwestern University, Icahn School of Medicine at Mount Sinai and international sites including Charité – Universitätsmedizin Berlin and Seoul National University Hospital. The meeting features plenaries, poster sessions and satellite symposia co-sponsored by organizations like Society of Surgical Oncology, American College of Surgeons and industry partners including AstraZeneca and Bristol Myers Squibb.

Publications and Guidelines

The society publishes peer-reviewed content and endorses guidelines developed in collaboration with journals and organizations such as Journal of Clinical Oncology, Neuro-Oncology, Lancet Oncology, New England Journal of Medicine and consensus panels modeled after statements from World Health Organization and National Comprehensive Cancer Network. Publications include systematic reviews with contributors from Cochrane Collaboration, practice guidelines reflecting input from American Society of Clinical Oncology and position papers co-authored with European Society for Medical Oncology and Society for Neuro-Oncology Latin America.

Education and Training Programs

Educational offerings include fellowships, workshops and webinars developed with training programs at Mayo Clinic Alix School of Medicine, University of California, Los Angeles, University of Sydney and specialized courses reflecting curricula from American Board of Neurological Surgery and Royal College of Physicians. The society provides mentorship linking early-career investigators from institutions like University of Toronto Faculty of Medicine, University of Cambridge, University of Melbourne with senior faculty from Memorial Sloan Kettering Cancer Center and Johns Hopkins University.

Collaborations and Impact on Neuro-oncology Policy

The society partners with regulatory bodies and policy organizations such as U.S. Food and Drug Administration, European Medicines Agency, Centers for Disease Control and Prevention and Health Canada to influence trial design, drug approval pathways and reimbursement standards. Its collaborations with advocacy groups like American Brain Tumor Association and international networks including Global Coalition for Adaptive Research have informed guideline adoption in health systems represented by NHS England, Australian Department of Health and provincial agencies in Ontario Ministry of Health. These engagements have shaped clinical trial endpoints and policy decisions similar to reforms influenced by Patient-Centered Outcomes Research Institute and multinational task forces convened by World Health Organization.

Category:Medical associations